Task Force adds Inflection Medicine and National Kidney Foundation

The Health Care Transformation Task Force expanded its coalition on Aug. 13, 2026, welcoming Inflection Medicine and the National Kidney Foundation as new members. The additions are meant to strengthen the group’s push toward value-based care, accountable care and more coordinated health care delivery.

Why it matters: - The Health Care Transformation Task Force is adding more clinical, policy and patient-focused expertise to its coalition. - The new members are expected to help shape value-based care, care delivery, payment and policy work across the health system. - The expansion comes as the Task Force continues pushing to accelerate accountable care and lower costs while improving outcomes.

What happened: - The Health Care Transformation Task Force said on Aug. 13, 2026, that Inflection Medicine and the National Kidney Foundation are joining as its newest members. - The two organizations are entering a coalition that includes providers, payers, purchasers and patients. - The Task Force said the additions will support its work to accelerate adoption of value-based care.

The details: - Task Force Chair Sean Cavanaugh said both organizations bring expertise and perspectives that will help build a more effective, coordinated and sustainable health care system. - Inflection Medicine CEO Sean Emerson George said the company was created to make precision medicine easier for clinicians to use in ways that improve outcomes and lower total cost of care. - George said Inflection Medicine wants to support personalized, data-driven approaches to value-based care. - National Kidney Foundation Vice President of Health Policy and Clinical Outcomes Miriam Godwin said kidney disease affects 37 million U.S. adults and most are unaware they have it. - Godwin said addressing kidney disease requires coordinated, person-centered approaches focused on awareness, access to care and clinical outcomes. - The National Kidney Foundation said it wants to work with the Task Force on care models and policies that better support people living with kidney disease, their families and clinicians. - Task Force CEO Theresa Dreyer said the new members will help inform new approaches to care delivery, payment and policy as the group works toward accountable care. - More information is available here.

Between the lines: - The membership adds a precision medicine company and a major disease-focused nonprofit to a coalition built around systemwide care redesign. - The mix suggests the Task Force is trying to broaden its influence across both clinical innovation and condition-specific advocacy. - The kidney disease focus also points to continued attention on high-cost chronic conditions where early detection and care coordination can change outcomes.

What's next: - Inflection Medicine and the National Kidney Foundation are expected to take part in the Task Force’s collaborative work on value-based care. - Their input could feed into future recommendations on care delivery, payment models and policy. - The Task Force said the additions will support its broader transition to accountable care.